Research into the rising incidence of cancer among young individuals has generated more questions than definitive answers. While one study indicates that increasing obesity rates may account for a fraction of this trend, it doesn’t provide a comprehensive explanation.

According to Montserrat Garcia-Crosas from the Institute of Cancer Research (ICR) in London, the main takeaway is that although Body Mass Index (BMI) serves as a significant indicator, much of the increase remains unexplained.

Numerous global studies have documented a rise in cancer cases among adults under 50. Notably, the incidence of colorectal cancer has surged by about 50% in countries including the United States, Australia, and Canada since the 1990s.

To investigate the reasons behind this trend, Garcia-Crosas and colleagues analyzed cancer data in the UK alongside population trends related to risk factors such as obesity. Their findings indicated that 11 types of cancer are rising among individuals aged 20 to 49, with breast and colorectal cancers being the most prevalent. Other malignancies include liver, kidney, and pancreatic cancers, exhibiting growth rates between 1% and 6% annually.

The researchers discovered that the incidence of nine out of these 11 cancers was also increasing in individuals over 50, suggesting some common underlying factors. However, ovarian cancer and colorectal cancer were exceptions to this pattern, as noted by Garcia-Crosas.

The team also explored behavioral factors linked to these 11 cancers as identified by the International Agency for Research on Cancer, which include alcohol consumption, smoking, physical inactivity, body mass index, and dietary habits related to fiber and processed meats. “These researchers provide the strongest evidence connecting these factors,” Garcia-Crosas stated.

Despite the stable or improving nature of these risk factors over time, BMI remains a consistent concern, particularly given the rising rates of obesity. However, the link between obesity and the increase in cancer among young people is only partially understood. For instance, only about 20% of the rise in colorectal cancer among young women can be attributed to increasing BMI, as per Garcia-Crosas.

According to team member Mark Gunter at Imperial College London, extensive research is currently ongoing to identify the causes of this troubling trend. Potential factors being examined include a higher consumption of ultra-processed foods, substances known as PFAS (forever chemicals), and antibiotics affecting the gut microbiome.

Your analysis suggests that the increase in cancer cases among youths likely stems from a combination of elements rather than a single cause, and they could not exclude the possibility that diagnostic practices may also be influencing these statistics.

This rise should also be considered in context, as highlighted by Amy Berrington at ICR. In the UK, only about 3,000 bowel cancer cases are reported annually among individuals aged 20 to 49. Consequently, a 3% increase signifies approximately 100 more cases each year. “These trends are relative, and the overall increase in cases remains modest,” Berrington elaborated.

The study did not include cervical cancer due to the significant decrease in cases among women who received the HPV vaccine during childhood.

Looking ahead, Berrington draws attention to data through 2023, expressing optimism as the upward trend seems to be stabilizing. Furthermore, if obesity is a contributing factor to the rise in cancer diagnoses, emerging GLP-1 weight loss medications, such as semaglutide, may offer a potential solution. “Should obesity rates decline due to the adoption of these medications, we could witness a reduction in some obesity-related cancers in the future,” Professor Gunter concluded.